Dr Reddys Drug Patent Portfolio
Dr Reddys owns 1 orange book drug protected by 1 US patent Given below is the list of Dr Reddys's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US10993952 | Stable ready to use cyclophosphamide liquid formulations | 15 Feb, 2036 | Active |
Latest Legal Activities on Dr Reddys's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Dr Reddys.
Activity | Date | Patent Number |
---|---|---|
Payment of Maintenance Fee, 4th Year, Large Entity | 30 May, 2024 | US10849916 |
Payment of Maintenance Fee, 4th Yr, Small Entity | 08 May, 2024 | US10993952 (Litigated) |
Recordation of Patent Grant Mailed
Critical
| 12 Jul, 2022 | US11382923 |
Patent Issue Date Used in PTA Calculation
Critical
| 12 Jul, 2022 | US11382923 |
Email Notification
Critical
| 23 Jun, 2022 | US11382923 |
Issue Notification Mailed
Critical
| 22 Jun, 2022 | US11382923 |
Dispatch to FDC | 08 Jun, 2022 | US11382923 |
Application Is Considered Ready for Issue
Critical
| 08 Jun, 2022 | US11382923 |
Issue Fee Payment Received
Critical
| 06 Jun, 2022 | US11382923 |
Issue Fee Payment Verified
Critical
| 06 Jun, 2022 | US11382923 |
Letter Accepting Correction of Inventorship Under Rule 1.48 | 06 May, 2022 | US11382923 |
Email Notification
Critical
| 06 May, 2022 | US11382923 |
Filing Receipt - Updated | 06 May, 2022 | US11382923 |
Miscellaneous Incoming Letter | 03 May, 2022 | US11382923 |
Email Notification
Critical
| 25 Apr, 2022 | US11382923 |
Dr Reddys's Family Patents
Dr Reddys Drug List
Given below is the complete list of Dr Reddys's drugs and the patents protecting them.
1. Cyclophosphamide
Cyclophosphamide is protected by 1 patent, which is still active. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US10993952 | Stable ready to use cyclophosphamide liquid formulations |
15 Feb, 2036
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cyclophosphamide's drug page